Upgrade to SI Premium - Free Trial

aTyr Pharma (ATYR)

0.49 0.00 (0.00%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (8/12/26)

Latest Headlines

aTyr Pharma to present efzofitimod subgroup data at WASOG 2026 July 15, 2026 8:00 AM - StreetInsider aTyr Pharma to Present Subgroup Analysis of Phase 3 EFZO-FIT™ Study of Efzofitimod in Pulmonary Sarcoidosis at WASOG 2026 July 15, 2026 8:00 AM - Globe NewsWire Form SCHEDULE 13G/A aTYR PHARMA INC Filed by: FEDERATED HERMES, INC. July 8, 2026 7:37 AM - SEC Filing Life Sciences Virtual Investor Forum Presentations Now Available for On-Demand Viewing June 26, 2026 8:35 AM - StreetInsider Life Sciences Virtual Investor Forum Agenda Announced for June 24th & 25th June 23, 2026 8:35 AM - Globe NewsWire Life Sciences Virtual Investor Forum Agenda Announced for June 24th & 25th June 23, 2026 8:35 AM - StreetInsider Form 8-K aTYR PHARMA INC For: Jun 03 June 8, 2026 4:04 PM - SEC Filing Form SCHEDULE 13G/A aTYR PHARMA INC Filed by: FMR LLC June 5, 2026 10:13 AM - SEC Filing Form 8-K aTYR PHARMA INC For: Jun 01 June 1, 2026 4:06 PM - SEC Filing Form 4 aTYR PHARMA INC For: May 27 Filed by: SCHIMMEL PAUL May 28, 2026 4:58 PM - SEC Filing Freedom Broker Upgrades aTyr Pharma (ATYR) to Buy May 20, 2026 9:01 AM - StreetInsider Form 10-Q aTYR PHARMA INC For: Mar 31 May 15, 2026 4:04 PM - SEC Filing Form 8-K aTYR PHARMA INC For: May 15 May 15, 2026 8:03 AM - SEC Filing aTyr Pharma Announces First Quarter 2026 Results and Provides Corporate Update May 15, 2026 8:00 AM - Globe NewsWire Form 4 aTYR PHARMA INC For: May 11 Filed by: Coughlin Timothy May 13, 2026 4:18 PM - SEC Filing Form 4 aTYR PHARMA INC For: May 11 Filed by: BENEVICH ERIC May 13, 2026 4:16 PM - SEC Filing Form 4 aTYR PHARMA INC For: May 11 Filed by: Gross Jane A May 13, 2026 4:14 PM - SEC Filing Form 4 aTYR PHARMA INC For: May 11 Filed by: Lucas Svetlana May 13, 2026 4:12 PM - SEC Filing Form 4 aTYR PHARMA INC For: May 11 Filed by: Zaknoen Sara May 13, 2026 4:11 PM - SEC Filing Form 4 aTYR PHARMA INC For: May 11 Filed by: SCHIMMEL PAUL May 13, 2026 4:08 PM - SEC Filing aTyr Pharma to Participate in Upcoming Investor Conferences May 13, 2026 4:01 PM - Globe NewsWire Form 8-K aTYR PHARMA INC For: May 11 May 11, 2026 4:04 PM - SEC Filing aTyr Pharma plans new phase 3 trial for lung disease drug May 11, 2026 4:01 PM - StreetInsider aTyr Pharma Provides Regulatory and Clinical Update for Efzofitimod in Pulmonary Sarcoidosis Following FDA Type C Meeting May 11, 2026 4:01 PM - Globe NewsWire Full Article List